JP2019502719A5 - - Google Patents

Download PDF

Info

Publication number
JP2019502719A5
JP2019502719A5 JP2018536488A JP2018536488A JP2019502719A5 JP 2019502719 A5 JP2019502719 A5 JP 2019502719A5 JP 2018536488 A JP2018536488 A JP 2018536488A JP 2018536488 A JP2018536488 A JP 2018536488A JP 2019502719 A5 JP2019502719 A5 JP 2019502719A5
Authority
JP
Japan
Prior art keywords
group
nociception
corneal nociception
patient
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536488A
Other languages
English (en)
Japanese (ja)
Other versions
JP6752439B2 (ja
JP2019502719A (ja
Filing date
Publication date
Priority claimed from US15/006,085 external-priority patent/US9827225B2/en
Application filed filed Critical
Publication of JP2019502719A publication Critical patent/JP2019502719A/ja
Publication of JP2019502719A5 publication Critical patent/JP2019502719A5/ja
Application granted granted Critical
Publication of JP6752439B2 publication Critical patent/JP6752439B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536488A 2016-01-25 2017-01-24 眼表面の侵害受容を処置するためのプロスタサイクリンアンタゴニストの使用 Active JP6752439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/006,085 US9827225B2 (en) 2016-01-25 2016-01-25 Use of prostacyclin antagonists for treating ocular surface nociception
US15/006,085 2016-01-25
PCT/US2017/014677 WO2017132115A1 (en) 2016-01-25 2017-01-24 Use of prostacyclin antagonists for treating ocular surface nociception

Publications (3)

Publication Number Publication Date
JP2019502719A JP2019502719A (ja) 2019-01-31
JP2019502719A5 true JP2019502719A5 (https=) 2020-02-27
JP6752439B2 JP6752439B2 (ja) 2020-09-09

Family

ID=59360031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536488A Active JP6752439B2 (ja) 2016-01-25 2017-01-24 眼表面の侵害受容を処置するためのプロスタサイクリンアンタゴニストの使用

Country Status (10)

Country Link
US (4) US9827225B2 (https=)
EP (1) EP3407975B1 (https=)
JP (1) JP6752439B2 (https=)
KR (1) KR20180104108A (https=)
CN (1) CN108883307B (https=)
AU (1) AU2017212343B2 (https=)
CA (1) CA3012197A1 (https=)
ES (1) ES2894916T3 (https=)
MX (1) MX379497B (https=)
WO (1) WO2017132115A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827225B2 (en) * 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception
SG11202107260VA (en) * 2019-02-15 2021-08-30 Novartis Ag Methods for treating ocular surface pain
WO2022170112A1 (en) * 2021-02-05 2022-08-11 Jenivision Inc. Compositions and methods for periorbital administration of ep2 receptor agonists
KR20230158076A (ko) * 2021-03-18 2023-11-17 제니비젼 인크. 눈 질환을 치료하기 위한 방법 및 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008585A1 (en) * 1992-10-13 1994-04-28 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
NZ331480A (en) * 1997-09-04 2000-02-28 F 2-(Arylphenyl)amino-imidazoline derivatives and pharmaceutical compositions
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
WO2002040453A1 (en) * 2000-11-14 2002-05-23 F. Hoffmann-La Roche Ag Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
CN100372532C (zh) * 2003-05-01 2008-03-05 弗·哈夫曼-拉罗切有限公司 用作ip拮抗剂的咪唑啉-2-基氨基苯基酰胺
US9610990B2 (en) * 2009-05-08 2017-04-04 Titan Trailers Inc. Apparatus and method for warming the floor of a trailer
AU2012358983B2 (en) 2011-12-21 2017-09-14 Allergan, Inc. Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
US9321745B2 (en) 2013-03-12 2016-04-26 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid IP receptors
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
US9827225B2 (en) 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception

Similar Documents

Publication Publication Date Title
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
JP2019089849A5 (https=)
JP2019536784A5 (https=)
JP2019502719A5 (https=)
JP2018529693A5 (https=)
JP2019532931A (ja) 眼瞼炎の治療に使用するための医薬組成物
RU2017129247A (ru) Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний
RU2018114926A (ru) Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
CN119546278A (zh) 两性离子在眼用局部乳膏组合物和制剂中的新应用
CH711969A2 (it) Composizione per il trattamento della presbiopia.
JP6014033B2 (ja) 防腐剤無添加ビマトプロストおよびチモロール溶液
JP2013534527A5 (https=)
RU2017145545A (ru) Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы
JP2018528169A5 (https=)
JP2013534527A (ja) コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物
JP2020531511A5 (https=)
JP2017527600A5 (https=)
EA201300314A1 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
JP6871400B2 (ja) 眼表面疾患の治療のための製剤および関連方法
JP2023168547A (ja) 眼科組成物
FI2765988T3 (fi) Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus
CN103841968A (zh) 眼睑治疗方法
RU2017111579A (ru) Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина
JP2017533228A5 (https=)
JPWO2019166631A5 (https=)